{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:47:44Z","timestamp":1793227664554,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead","doi-asserted-by":"publisher","award":["GLD15\/00270"],"award-info":[{"award-number":["GLD15\/00270"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SEINORTE"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejim.2019.06.005","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:39:20Z","timestamp":1560793160000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-7971","authenticated-orcid":false,"given":"Patricia","family":"P\u00e9rez-Matute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"\u00cd\u00f1iguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Villanueva-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Recio-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana Morano","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Castro","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds E.","family":"Morano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Oteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2019.06.005_bb0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1017\/S0950268810001421","article-title":"Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991-2006","volume":"139","author":"McDonald","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ejim.2019.06.005_bb0010","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/gut.2006.113217","article-title":"Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study","volume":"56","author":"Neal","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2019.06.005_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-015-9684-3","article-title":"Hepatitis C virus as a systemic disease: reaching beyond the liver","volume":"10","author":"Gill","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ejim.2019.06.005_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11904-015-0274-8","article-title":"Extrahepatic manifestations of hepatitis C infection: navigating CHASM","volume":"12","author":"Sherman","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.ejim.2019.06.005_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13027-016-0076-7","article-title":"Systemic manifestations of hepatitis C infection","volume":"11","author":"Tang","year":"2016","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.ejim.2019.06.005_bb0035","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC group. Multidepartment virus C","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2019.06.005_bb0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejim.2019.06.005_bb0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3748\/wjg.v6.i6.805","article-title":"Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C","volume":"6","author":"Yan","year":"2000","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0050","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","article-title":"Gut microbiota changes and chronic hepatitis C virus infection","volume":"11","author":"Preveden","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bpg.2016.02.004","article-title":"Intestinal microbiota in liver disease","volume":"30","author":"Haque","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trsl.2016.07.005","article-title":"Gut microbiome and liver disease","volume":"179","author":"Betrapally","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.ejim.2019.06.005_bb0065","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/liv.13485","article-title":"Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls","volume":"38","author":"Heidrich","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2019.06.005_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","article-title":"Gut microbiome alterations in patients with stage 4 hepatitis C","volume":"8","author":"Aly","year":"2016","journal-title":"Gut Pathog"},{"key":"10.1016\/j.ejim.2019.06.005_bb0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/cid\/ciy205","article-title":"Gut Dysbiosis associated with hepatitis C virus infection","volume":"67","author":"Inoue","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2019.06.005_bb0085","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/apt.15004","article-title":"Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis","volume":"48","author":"Ponziani","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2019.06.005_bb0090","article-title":"Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis","author":"Jiang","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.ejim.2019.06.005_bb0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/apt.13732","article-title":"HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients","volume":"44","author":"Bajaj","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2019.06.005_bb0100","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1073\/pnas.1000080107","article-title":"Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample","volume":"108","author":"Caporaso","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2019.06.005_bb0105","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AEM.03006-05","article-title":"Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB","volume":"72","author":"DeSantis","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/bty113","article-title":"Updating the 97% identity threshold for 16S ribosomal RNA OTUs","author":"Edgar","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejim.2019.06.005_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1590\/S0074-02762010000100003","article-title":"Tissue and serum immune response in chronic hepatitis C with mild histological lesions","volume":"105","author":"RV","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ejim.2019.06.005_bb0120","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/JVI.73.6.4713-4720.1999","article-title":"Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation","volume":"73","author":"Marusawa","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0125","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.ejim.2019.06.005_bb0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1478-3231.1999.tb00078.x","article-title":"Enhanced expression of interleukin-6 in chronic hepatitis C","volume":"19","author":"Oyanagi","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.ejim.2019.06.005_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167934","article-title":"DAAs rapidly reduce inflammation but increase serum VEGF level: a rationale for tumor risk during anti-HCV treatment","volume":"11","author":"Villani","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2019.06.005_bb0140","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1089\/aid.2012.0348","article-title":"Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems","volume":"29","author":"Fuster","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.ejim.2019.06.005_bb0145","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2019.06.005_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170028","article-title":"High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments","volume":"12","author":"Nien","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2019.06.005_bb0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jvh.12769","article-title":"Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients","volume":"25","author":"Merchante","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejim.2019.06.005_bb0160","first-page":"91","article-title":"Evaluation of bacterial translocation in patients with chronic HCV infection","volume":"52","author":"Munteanu","year":"2014","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.ejim.2019.06.005_bb0165","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2011.06.063","article-title":"Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection","volume":"141","author":"Sandler","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2019.06.005_bb0170","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/microorganisms3040759","article-title":"Gut microbiota and host reaction in liver diseases","volume":"3","author":"Fukui","year":"2015","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejim.2019.06.005_bb0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","article-title":"The role of short-chain fatty acids in health and disease","volume":"121","author":"Tan","year":"2014","journal-title":"Adv Immunol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00130-17","article-title":"Colonic butyrate-producing communities in humans: an overview using omics data","volume":"2","author":"Vital","year":"2017","journal-title":"mSystems"},{"key":"10.1016\/j.ejim.2019.06.005_bb0185","doi-asserted-by":"crossref","first-page":"34055","DOI":"10.1038\/srep34055","article-title":"Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2019.06.005_bb0190","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2019.06.005_bb0195","first-page":"26","article-title":"Intestinal microbiota assessment in cirrhotic patients from a Mexican mestizo population","volume":"84","author":"Perez-Monter","year":"2019","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.ejim.2019.06.005_bb0200","doi-asserted-by":"crossref","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","article-title":"Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation","volume":"303","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0205","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1038\/s41598-018-22629-7","article-title":"A Lachnospiraceae-dominated bacterial signature in the fecal microbiota of HIV-infected individuals from Colombia, South America","volume":"8","author":"San-Juan-Vergara","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2019.06.005_bb0210","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/MEG.0000000000000214","article-title":"Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease","volume":"26","author":"Kwak","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0215","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","article-title":"Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology","volume":"65","author":"Dao","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2019.06.005_bb0220","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2019.06.005_bb0225","doi-asserted-by":"crossref","first-page":"16643","DOI":"10.1038\/srep16643","article-title":"Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice","volume":"5","author":"Schneeberger","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2019.06.005_bb0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/exd.13463","article-title":"The Akkermansia muciniphila is a gut microbiota signature in psoriasis","volume":"27","author":"Tan","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0235","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fmicb.2017.01765","article-title":"Next-generation beneficial microbes: the case of Akkermansia muciniphila","volume":"8","author":"Cani","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ejim.2019.06.005_bb0240","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/bioinformatics\/btv183","article-title":"Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA","volume":"31","author":"Kelly","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejim.2019.06.005_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052078","article-title":"Hypothesis testing and power calculations for taxonomic-based human microbiome data","volume":"7","author":"La Rosa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2019.06.005_bb0250","doi-asserted-by":"crossref","first-page":"21526","DOI":"10.7448\/IAS.20.1.21526","article-title":"Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients","volume":"20","author":"Villanueva-Millan","year":"2017","journal-title":"J Int AIDS Soc"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051930189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051930189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:30:50Z","timestamp":1760607050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362051930189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":50,"alternative-id":["S095362051930189X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2019.06.005","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2019.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}